SNY

Sanofi News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Sanofi SNY NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
-0.64 -1.23% 51.42 11:03:11
Open Price Low Price High Price Close Price Prev Close
51.51 51.41 51.59 52.06
more quote information »

Recent News

Date Time Source Heading
4/23/202107:28EDGARPost-effective Amendment to an S-8 Filing (s-8 Pos)
4/19/202101:50SEEKSanofi's Sarclisa OK'd in European as second indication for..
4/13/202114:57EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
4/12/202103:55SEEKSanofi to invest €400M in a production site in Singapore
4/12/202103:34TRMNSanofi Snaps Up Tidal Therapeutics For $160M
4/12/202103:34DJNC4X Discovery Shares Jump on Sanofi Licensing Agreement
4/12/202101:54DJNSanofi to Invest in Vaccine Production Site in Singapore
4/09/202114:31DJNSanofi Buys Biotech Startup Tidal Therapeutics for Initial..
4/09/202114:12SEEKSanofi targets mRNA based medicine with acquisition of Tidal..
4/07/202107:00PRNUSSanofi expands its social commitments, creates nonprofit..
4/07/202106:06DJNSanofi Creates Unit to Increase Poor Countries' Access to..
4/02/202114:22EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
4/01/202101:37DJNSanofi: FDA Approves Sarclisa With Carfilzomib,..
3/31/202118:13PRNUSFDA approves Sarclisa® (isatuximab-irfc) in combination with..
3/31/202117:39SEEKFDA approves Sanofi's Sarclisa for another multiple myeloma..
3/31/202112:12SEEKLava Therapeutics surges as Sanofi discloses stake
3/31/202110:50DJNSanofi Plans $700 Million Canada Plant to Boost Fluzone..
3/31/202110:10SEEKSanofi to build new facility in Canada to boost influenza..
3/20/202116:00SEEKNurix falls dramatically in late week trading after inking..
3/19/202115:49EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/19/202108:35SEEKFDA approves Johnson & Johnson's multiple sclerosis drug..
3/19/202104:23DJNOxford BioMedica Says Sanofi to Terminate Collaboration,..
3/17/202116:44SEEKSangamo highlights EMA opinion on BIVV003 Orphan Designation
3/15/202107:00SEEKRegeneron, Sanofi winds up late-stage Libtayo study after..
3/15/202106:41DJNRegeneron, Sanofi: Positive Libtayo Phase 3 Study in..
3/13/202110:16DJNBioNTech Recruits Rivals to Boost Covid-19 Vaccine..
3/13/202108:29DJNBioNTech Recruits Rivals to Boost Covid-19 Vaccine..
3/12/202113:04SEEKMerck and Pfizer among top picks to lead 2021 biopharma M&A..
3/12/202102:01DJNSanofi, Translate Bio Start Phase 1/2 Clinical Trial of..
3/08/202116:21EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/04/202110:26EDGARAnnual and Transition Report (foreign Private Issuer) (20-f)
3/04/202106:26DJNRegeneron, Sanofi: FDA to Review Dupixent for Asthma Attacks..
3/04/202101:32SEEKFDA accepts Regeneron, Sanofi's Dupixent application for..
2/23/202116:27EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/23/202113:43DJNCorrection to Covid-19 Vaccine Rival Drugmakers Article
2/23/202107:29DJNTo Make More Covid-19 Vaccines, Rival Drugmakers Team Up
2/22/202113:45DJNRegeneron, Sanofi Gets FDA OK of Libtayo in Advanced..
2/22/202113:24SEEKRegeneron and Sanofi get FDA approval for Libtayo in..
2/22/202106:29DJNSanofi, GSK Start New Covid-19 Vaccine Study After Setback
2/19/202113:49EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/16/202117:02EDGARStatement of Ownership (sc 13g)
2/13/202122:56SEEKCOVID-19 reshapes global vaccine landscape: Barron’s
2/12/202107:06SEEKRegeneron, Sanofi's Libtayo shows extended overall survival..
2/11/202115:18EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/11/202106:45SEEKRegeneron/ Sanofi score an early win for Libtayo in basal..
2/06/202123:13SEEKIsrael hospital says new COVD-19 therapy cured a majority of..
2/05/202116:51DJNADRs End Higher
2/05/202112:16EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/05/202109:38DJNSanofi Raises Cost-Savings, Margin Targets as Dupixent Sales..
2/05/202103:21DJNSanofi Swings to Profit in 4Q; Sales Decline -- Update
See more news about this stock »


Your Recent History
NASDAQ
SNY
Sanofi
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.